Geode Capital Management »

Tscan Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.3M 414k 7.94
2023-09-30 $789k 308k 2.56
2023-06-30 $292k 117k 2.50
2023-03-31 $211k 100k 2.10
2022-12-31 $163k 100k 1.62
2022-09-30 $307k 101k 3.05
2022-06-30 $107k 34k 3.14
2022-03-31 $92k 33k 2.77
2021-12-31 $114k 25k 4.48
2021-09-30 $106k 13k 8.29